Skip to main content

Mekhail Adel's Form 4 filing

Prestige Consumer Healthcare Inc. (PBH) · filed Feb 20, 2024

Accession no.
0001104659-24-025498
Filed
Feb 20, 2024
Trade date
Feb 15, 2024
Filing delay
5 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.07M. It was filed 5 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mekhail AdelCIK 0001776953Officer (EVP, Marketing & Sales)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 15, 2024Common Stock, par value $0.01 per shareMOption exerciseAcquired+4,000$30.19+$120,76022,681Direct
Feb 15, 2024Common Stock, par value $0.01 per shareSSaleDisposed−4,000$69.21−$276,84018,681Direct
Feb 15, 2024Common Stock, par value $0.01 per shareMOption exerciseAcquired+11,549$39.98+$461,729.0230,230Direct
Feb 15, 2024Common Stock, par value $0.01 per shareSSaleDisposed−11,549$69.08−$797,804.9218,681Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 15, 2024Common StockMOption exerciseDisposed−4,000$0.00$00Direct
Feb 15, 2024Common StockMOption exerciseDisposed−11,549$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)